Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

OnabotulinumtoxinAOptimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

Sponsor:

The Methodist Hospital Research Institute

Code:

NCT06059066

Conditions

Neurogenic Bladder

Lower Urinary Tract Symptoms

Overactive Bladder

Neuro: Neurogenic Bladder

Neurogenic Detrusor Overactivity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Standard number of injection sites

Reduced number of injection sites

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by The Methodist Hospital Research Institute on 2025-05-09.